Sponsored Links

BRIEF-J&J says expects generic competition in early 2013 for Concerta

Tue Jan 22, 2013 10:06am EST

Jan 22 (Reuters) - Johnson & Johnson : * J&J says expects generic competition in early 2013 for Concerta

attention defict disorder drug * J&J says expects 2013 tax rate of 20 percent, below 2012 rate
Stocks
Markets
Healthcare
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.